site stats

Ganx stock news

WebGANX Valuation Summary. GANX's price/sales ratio is 267.8; this is 12652.38% higher than that of the median Healthcare stock. Over the past 23 months, GANX's EV/EBIT ratio … WebApr 11, 2024 · According to 10 analysts, the average rating for GANX stock is "Buy." The 12-month stock price forecast is $9.12, which is an increase of 102.67% from the latest …

Is Gain Therapeutics Inc

WebGain Therapeutics Inc. advanced stock charts by MarketWatch. View GANX historial stock data and compare to other stocks and exchanges. WebMar 7, 2024 · Gain Therapeutics Inc (GANX) stock is up 9.67% while the S&P 500 is down -0.82% as of 11:10 AM on Tuesday, Mar 7. GANX is higher by $0.35 from the previous closing price of $3.62 on volume of 2,407 shares. Over the past year the S&P 500 is lower by -4.43% while GANX is higher by 18.15%. GANX lost -$1.36 per share the over the … takeuchi tb216 mini excavator specs https://ewcdma.com

Gain Therapeutics, Inc. (GANX) Stock Price, News, Quote & History ...

WebGain Therapeutics, Inc. Common Stock (GANX) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets. WebMar 13, 2024 · A rating of 89 puts Gain Therapeutics Inc near the top of the Healthcare sector according to InvestorsObserver.Gain Therapeutics Inc's score of 89 means that it ranks higher than 89% of stocks in the sector. In addition, its overall score of 73 ranks it higher than 73% of all stocks. WebApr 12, 2024 · April 12, 2024 - 4:30 pm. BETHESDA, Md., April 12, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced the appointment of C. Evan Ballantyne as the Company’s … twitch oyatsu

Where Does Wall Street Think Gain Therapeutics Inc (GANX) Stock …

Category:Gain Therapeutics - GANX - Stock Price Today - Zacks

Tags:Ganx stock news

Ganx stock news

GANX

Web1 day ago · News; Brokers; More; Get started. News flow. Gain Therapeutics Appoints C. Evan Ballantyne As Chief Financial Officer. Apr 12, 2024 20:33 UTC. AGEN G GANX. Agenus Inc AGEN: GAIN THERAPEUTICS APPOINTS C. EVAN BALLANTYNE AS CHIEF FINANCIAL OFFICER. GAIN THERAPEUTICS INC - BALLANTYNE SUCCEEDS … WebFind the latest Gain Therapeutics, Inc. (GANX) stock quote, history, news and other vital information to help you with your stock trading and investing. Interactive Chart for Gain Therapeutics, Inc. (GANX), analyze all the data with a … Find the latest Gain Therapeutics, Inc. (GANX) stock discussion in Yahoo … Discover historical prices for GANX stock on Yahoo Finance. View daily, weekly or … Find out all the key statistics for Gain Therapeutics, Inc. (GANX), including … Get the detailed quarterly/annual income statement for Gain Therapeutics, Inc. … See the company profile for Gain Therapeutics, Inc. (GANX) including … Holder Shares Date Reported % Out Value; Fidelity Extended Market Index Fund: … See Gain Therapeutics, Inc. (GANX) stock analyst estimates, including earnings … View the basic GANX option chain and compare options of Gain Therapeutics, … Get the latest Gain Therapeutics, Inc. (GANX) stock news and headlines to …

Ganx stock news

Did you know?

Web1 day ago · Apr. 12, 2024 4:41 PM ET Gain Therapeutics, Inc. (GANX) By: Dania Nadeem, SA News Editor. Gain Therapeutics ( NASDAQ: GANX) said it had appointed Evan Ballantyne as the Chief Financial Officer ... Web$GANX Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer. 12 Apr 2024 20:31:00

WebSep 8, 2024 · On average, analysts give GANX a Strong Buy rating. The average price target is $30, which means analysts expect the stock to rise by 236.32% over the next twelve months. That average ranking earns GANX an Analyst Rating of 75, which is better than 75% of stocks based on data compiled by InvestorsObserver. WebGANX: Get the latest Gain Therapeutics stock price and detailed information including GANX news, historical charts and realtime prices.

WebApr 8, 2024 · 5 brokerages have issued 12-month price objectives for Gain Therapeutics' stock. Their GANX share price forecasts range from $5.00 to $10.00. On average, they … WebFind the latest Gain Therapeutics, Inc. (GANX) stock quote, history, news and other vital information to help you with your stock trading and investing.

WebMar 31, 2024 · finance.yahoo.com - March 29 at 11:15 AM. Gain Therapeutics, Inc.: Gain Therapeutics Reports Full Year 2024 Financial Results and Business Update. …

Web2 days ago · BETHESDA, Apr 12, 2024 (GLOBE NEWSWIRE via COMTEX) -- BETHESDA, Md., April 12, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a biotechnology company ... twitchozisan-twitchWeb1 day ago · Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer. BETHESDA, Md., April 12, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company ... takeuchi tb 216 specsWebBETHESDA, Md., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company transforming drug discovery with its proprietary computational discovery platform identifying novel allosteric binding sites and creating small molecule treatments, today announced that Matthias ... takeuchi tb216 partsWebFind the latest GANX stock news. View the Gain Therapeutics news and quotes for today, invesment news based on TipRanks market-leading research tools. Top Stocks. Top … takeuchi tb230 specsWebMay 19, 2024 · Of the seven analysts that rated the stock, six have rated it Buy. A $38.86 consensus price target represents an 88.3% increase from its last closing price of $20.64. Gain Therapeutics, Inc. GANX develops various therapeutics to treat diseases caused by protein misfolding. Its primary focus is on rare genetic diseases and neurological disorders. twitch p1kapeachWebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price … twitch oxygen not includedWebBETHESDA, Md., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company transforming drug … takeuchi tb230 reviews